Form 8-K - Current report:
SEC Accession No. 0001193125-24-279061
Filing Date
2024-12-16
Accepted
2024-12-16 08:25:30
Documents
19
Period of Report
2024-12-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d899983d8k.htm   iXBRL 8-K 34920
2 EX-1.1 d899983dex11.htm EX-1.1 183947
3 EX-4.1 d899983dex41.htm EX-4.1 80175
4 EX-5.1 d899983dex51.htm EX-5.1 14436
5 EX-99.1 d899983dex991.htm EX-99.1 7753
9 GRAPHIC g899983g1214030403908.jpg GRAPHIC 2529
10 GRAPHIC g899983g1214030638372.jpg GRAPHIC 4651
  Complete submission text file 0001193125-24-279061.txt   539349

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA ino-20241212.xsd EX-101.SCH 2834
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE ino-20241212_lab.xml EX-101.LAB 17996
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ino-20241212_pre.xml EX-101.PRE 11252
21 EXTRACTED XBRL INSTANCE DOCUMENT d899983d8k_htm.xml XML 3642
Mailing Address 660 W. GERMANTOWN PIKE SUITE 110 PLYMOUTH MEETING PA 19462
Business Address 660 W. GERMANTOWN PIKE SUITE 110 PLYMOUTH MEETING PA 19462 8584103134
INOVIO PHARMACEUTICALS, INC. (Filer) CIK: 0001055726 (see all company filings)

EIN.: 330969592 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14888 | Film No.: 241550200
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)